HEPATOBILIARY TUMORS LABORATORY
HEPATOBILIARY TUMORS LABORATORY
Our group develops translational research focusing on the study of the pathogenesis and treatment of primary liver cancer, including hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA). In particular, we are interested in better comprehending the crosstalk interactions between cancer and stromal cells from the tumor microenvironment. We apply our results to discover new therapeutic targets and to develop novel therapies that improve tumor progression.